Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 11 949-956, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group

TE Moon, N Levine, B Cartmel, JL Bangert, S Rodney, Q Dong, YM Peng and DS Alberts
Department of Biomathematics, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

We conducted a randomized, double-blind, controlled trial to examine the efficacy of retinol supplementation on the incidence of first new nonmelanoma skin cancer in moderate-risk subjects. A total of 2297 free-living subjects were enrolled; subjects resided in Arizona (median age, 63 years) and had a history of more than 10 actinic keratoses and at most 2 squamous cell carcinoma (SCC) or basal cell carcinoma (BCC) skin cancers. Subjects were randomly assigned to receive oral retinol (25,000 IU) or placebo supplementation daily for up to 5 years. The primary end points for the trial were time to first new SCC or BCC. During a median follow-up time of 3.8 years, we found that 526 subjects had a first new skin cancer. Comparing retinol-supplemented subjects with placebo-supplemented subjects showed a hazard ratio for first new SCC of 0.74 (95% confidence interval, 0.56-0.99; P = 0.04). The hazard ratio of first new BCC for the retinol-supplemented subjects compared with those receiving placebo was 1.06 (95% confidence interval, 0.86-1.32; P = 0.36). Potentially adverse symptoms that were judged to be associated with retinol were rare (approximately 1% higher in the retinol group than in the control group). Therefore, we concluded that daily supplementation with 25,000 IU of retinol was effective in preventing SCC, although it did not prevent BCC.

This article has been cited by other articles:

				T. I Ibiebele, J. C van der Pols, M. C. Hughes, G. C Marks, G. M Williams, and A. C Green Dietary pattern in association with squamous cell carcinoma of the skin: a prospective study Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1401 - 1408. [Abstract] [Full Text] [PDF]

				G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-analysis JAMA, February 28, 2007; 297(8): 842 - 857. [Abstract] [Full Text] [PDF]

				F. L. Meyskens Jr. American Society of Preventive Oncology Distinguished Career Achievement Lecture 2006--Enjoy the Journey: The Long and Winding Road of Chemoprevention Agent Development. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2038 - 2041. [Full Text] [PDF]

				S. A. McNaughton, G. C. Marks, and A. C. Green Role of Dietary Factors in the Development of Basal Cell Cancer and Squamous Cell Cancer of the Skin Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1596 - 1607. [Abstract] [Full Text] [PDF]

				S. M. Lippman and B. Levin Cancer Prevention: Strong Science and Real Medicine J. Clin. Oncol., January 10, 2005; 23(2): 249 - 253. [Full Text] [PDF]

				P. R. Taylor and P. Greenwald Nutritional Interventions in Cancer Prevention J. Clin. Oncol., January 10, 2005; 23(2): 333 - 345. [Abstract] [Full Text] [PDF]

				G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, F. L. Meyskens Jr., G. S. Omenn, B. Valanis, and J. H. Williams Jr. The Beta-Carotene and Retinol Efficacy Trial: Incidence of Lung Cancer and Cardiovascular Disease Mortality During 6-Year Follow-up After Stopping {beta}-Carotene and Retinol Supplements J Natl Cancer Inst, December 1, 2004; 96(23): 1743 - 1750. [Abstract] [Full Text] [PDF]

				R. L. Sedjo, J. Ranger-Moore, J. Foote, N. E. Craft, D. S. Alberts, M.-J. Xu, and A. R. Giuliano Circulating Endogenous Retinoic Acid Concentrations among Participants Enrolled in a Randomized Placebo-Controlled Clinical Trial of Retinyl Palmitate Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1687 - 1692. [Abstract] [Full Text] [PDF]

				A. S. Tsao, E. S. Kim, and W. K. Hong Chemoprevention of Cancer CA Cancer J Clin, May 1, 2004; 54(3): 150 - 180. [Abstract] [Full Text] [PDF]

				D. Alberts, J. Ranger-Moore, J. Einspahr, K. Saboda, P. Bozzo, Y. Liu, X.-c. Xu, R. Lotan, J. Warneke, S. Salasche, et al. Safety and Efficacy of Dose-Intensive Oral Vitamin A in Subjects with Sun-Damaged Skin Clin. Cancer Res., March 15, 2004; 10(6): 1875 - 1880. [Abstract] [Full Text] [PDF]

				A. J. Duffield-Lillico, E. H. Slate, M. E. Reid, B. W. Turnbull, P. A. Wilkins, G. F. Combs Jr., H. K. Park, E. G. Gross, G. F. Graham, M. S. Stratton, et al. Selenium Supplementation and Secondary Prevention of Nonmelanoma Skin Cancer in a Randomized Trial J Natl Cancer Inst, October 1, 2003; 95(19): 1477 - 1481. [Abstract] [Full Text] [PDF]

				S. M. Lippman and W. K. Hong Cancer Prevention Science and Practice Cancer Res., September 15, 2002; 62(18): 5119 - 5125. [Full Text] [PDF]

				Managing solar keratoses DTB, May 1, 2002; 40(5): 33 - 35. [Abstract] [Full Text] [PDF]

				J. A. O'Shaughnessy, G. J. Kelloff, G. B. Gordon, A. J. Dannenberg, W. K. Hong, C. J. Fabian, C. C. Sigman, M. M. Bertagnolli, S. P. Stratton, S. Lam, et al. Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia Clin. Cancer Res., February 1, 2002; 8(2): 314 - 346. [Abstract] [Full Text] [PDF]

				S. M. Lippman and M. R. Spitz Lung Cancer Chemoprevention: An Integrated Approach J. Clin. Oncol., September 15, 2001; 19(90001): 74s - 82. [Abstract] [Full Text] [PDF]

				R A Sharma, A J Gescher, K J O'Byrne, and W P Steward Familiar drugs may prevent cancer Postgrad. Med. J., August 1, 2001; 77(910): 492 - 497. [Abstract] [Full Text] [PDF]

				X.-C. Xu, W. Y. L. Wong, L. Goldberg, S. C. Baer, J. E. Wolf, W. M. Ramsdell, D. S. Alberts, S. M. Lippman, and R. Lotan Progressive Decreases in Nuclear Retinoid Receptors during Skin Squamous Carcinogenesis Cancer Res., June 1, 2001; 61(11): 4306 - 4310. [Abstract] [Full Text] [PDF]

				S. M. Lippman, J. J. Lee, D. D. Karp, E. E. Vokes, S. E. Benner, G. E. Goodman, F. R. Khuri, R. Marks, R. J. Winn, W. Fry, et al. Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer J Natl Cancer Inst, April 18, 2001; 93(8): 605 - 618. [Abstract] [Full Text] [PDF]

				B. Cartmel, T. E. Moon, N. Levine, S. Rodney, and D. Alberts Predictors of Inactivation and Reasons for Participant Inactivation during a Skin Cancer Chemoprevention Study Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 999 - 1002. [Abstract] [Full Text]

				S. M. Lippman and R. Lotan Advances in the Development of Retinoids as Chemopreventive Agents J. Nutr., February 1, 2000; 130(2): 479 - 479. [Abstract] [Full Text]

				W. McCaskill-Stevens, E. T. Hawk, P. J. Flynn, and S. M. Lippman National Cancer Institute-Supported Cancer Chemoprevention Research: Coming of Age J. Clin. Oncol., November 1, 1999; 17(90001): 53 - 62. [Full Text] [PDF]

				Prevention of Cancer in the Next Millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research Cancer Res., October 1, 1999; 59(19): 4743 - 4758. [Full Text] [PDF]

				B. Cartmel, T. E Moon, and N. Levine Effects of long-term intake of retinol on selected clinical and laboratory indexes Am. J. Clinical Nutrition, May 1, 1999; 69(5): 937 - 943. [Abstract] [Full Text] [PDF]

				H. Vainio and M. Rautalahti An International Evaluation of the Cancer Preventive Potential of Vitamin A Cancer Epidemiol. Biomarkers Prev., January 1, 1999; 8(1): 107 - 109. [Abstract] [Full Text] [PDF]